buying opp at 2.6 c (now 2.9c), page-14

The good news will come in the form of the trial results.

These will either be out next month or the one after.

Yesterday marked the 2 month anniversary since the company announced that the 28 day patient monitoring period had concluded.. so we really dont have too long to wait now.

IMO the market will start pricing in a successful trial outcome and the SP will move north from here.

My investigations confirm Clyde's comments about the collation and report writing taking 3 months. But IMO if it gets to mid-December and everyone is in Christmas party mode, then the company could very well wait until mid-January to make the results public. Who knows. Im sure the option expiry will be a factor in their decision making.

Either way, its been 2 months since the trial officially concluded and the SP is below where it was when that was announced.

Sounds like a buying opportunity to me.